Morphle Labs (YC W20) — Robotic automation for cancer diagnostics - robotic microscopes &…
Morphle Labs appears in Y Combinator's company directory in the Winter 2020 batch, listed 2020-03-13. Robotic Automation for cancer diagnostics - Robotic Microscopes &….
Morphle Labs is a Y Combinator company in the Winter 2020 batch. Its directory entry describes it as: Robotic Automation for cancer diagnostics - Robotic Microscopes &…. The founder listed is Rohit Hiwale (Founder) (Y Combinator directory entry, March 13, 2020).
Get an email when Morphle Labs changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
Robotome: The High Throughput Robotic Microtomes for Blocks in and Slide Out. Facing & Sectioning at 500 slides per hour MorphoLens: AI-enabled 80X and 100X microscope slide scanners from Morphle Digital Pathology offer robust scanning, affordable variants enabling Telepathology & digital slide storage. Global shipping with a 60 day returns policy. RoboReq OCR: Handwriting OCR for medical requisit
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Rohit Hiwale
Founder
A product geek & a hard tech enthusiast solving unique problems in vision guide robotics starting with medical devices.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 44 companies held here in Healthcare › Medical Devices.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Morphle Labs?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Morphle Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Morphle Labs covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Morphle Labs: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
